怀孕期间慢性乙型肝炎的管理

StephenW

Management of chronic hepatitis B during pregnancy
Aysha Aslam Karen Joanie Campoverde Reyes Vijayram Reddy Malladi Rizwan Ishtiaq Daryl T Y Lau
Gastroenterology Report, goy025, https://doi.org/10.1093/gastro/goy025
Published:
24 July 2018

Abstract

Chronic hepatitis B is globally prevalent and is a major cause of cirrhosis and hepatocellular carcinoma. Despite immunoprophylaxis against hepatitis B in pregnancy, perinatal transmission still occurs in at least 10% of the children born to a mother with high level of viremia. Decisions regarding hepatitis B therapy during pregnancy must take into account the benefits and safety for both the mother and the unborn baby. In this review, we summarize the current treatment options for chronic hepatitis B with a focus on management during pregnancy and the evidence-based strategies to prevent vertical transmission of hepatitis B virus (HBV).
Chronic hepatitis B, pregnancy, nucleoside analogue, hepatitis B therapy
Topic:

    pregnancy hepatitis b hepatitis b, chronic mothers hepatitis b virus maternal transmission

StephenW

怀孕期间慢性乙型肝炎的管理
Aysha Aslam Karen Joanie Campoverde Reyes Vijayram Reddy Malladi Rizwan Ishtiaq Daryl T Y Lau
胃肠病学报告，goy025，https：//doi.org/10.1093/gastro/goy025
发布时间：
2018年7月24日

抽象

慢性乙型肝炎是全球流行的，并且是肝硬化和肝细胞癌的主要原因。尽管怀孕期间对乙型肝炎进行了免疫预防，但至少10％的患有高病毒血症的母亲所生的孩子仍然会发生围产期传播。怀孕期间关于乙型肝炎治疗的决定必须考虑到母亲和未出生婴儿的益处和安全性。在这篇综述中，我们总结了目前慢性乙型肝炎的治疗方案，重点是妊娠期间的管理和预防乙型肝炎病毒（HBV）垂直传播的循证策略。
慢性乙型肝炎，妊娠，核苷类似物，乙型肝炎治疗
话题：

    妊娠期乙型肝炎乙型肝炎，慢性母亲乙型肝炎病毒母体传播

StephenW

https://academic.oup.com/gastro/ ... stro/goy025/5057986